News | October 13, 2014

Single Radiation Treatment During Surgery for Early Stage Breast Cancer using Mobetron

Promising early data using electron beam presented at 8th International Conference of Intraoperative Radiotherapy

Single Radiation Treatment During Surgery Early Stage Breast Cancer Mobetron

October 13, 2014 — Catherine Philippson, M.D., of the Jules Bordet Institute, Brussels presented her institution’s experience treating 425 early stage breast cancer patients from February 2010 through February 2014 using Mobetron to deliver intraoperative electron beam radiotherapy (IOERT) as the sole radiation treatment with no post-operative radiotherapy to follow. The IOERT treatment, which is a therapeutic dose of radiation targeted directly at the tissue at highest risk for local recurrence, is delivered during the lumpectomy surgery to remove the cancer. The presentation of the Jules Bordet data took place at the 8th International Conference of Intraoperative Radiotherapy in Cologne, Germany on Sept. 27, 2014. Patients were enrolled in an institutional protocol that included women ages 40+, among other patient characteristics consistent with low risk/early stage breast cancer. With a median follow up of 23.6 months, the local recurrence rate was reported as 0.5 percent and acute and late toxicities were reported as low. Philippson concluded that ‘while these very early results in appropriately selected patients are encouraging, longer follow up is needed.’

Early stage breast cancer patients comprise the majority of those diagnosed annually in the United States. “For these patients to be able to complete radiation therapy during their lumpectomy surgery using Mobetron alleviates the significant burden of having to undergo three to six weeks of daily treatments. That combined with the fact that this approach is markedly less costly overall to the healthcare system than other post-operative radiotherapy approaches is of great significance in today’s healthcare climate.” said Mary Ann Slavik, a spokesperson for IntraOp Medical in Sunnyvale, Calif., makers of Mobetron, a mobile and self-shielding linear accelerator. Slavik commented, “We eagerly await the results of longer follow up to confirm these data.”

For more information: www.intraopmedical.com

Related Content

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium

GE Healthcare showcases Senographe Pristina with its add-on-biopsy kit at the breast imaging symposium in Hollywood, Florida. Photo by Greg Freiherr

Feature | Breast Imaging | April 23, 2019 | By Greg Freiherr
Signs of what the future may look like in women’s health dotted the exhibit floor of the...
Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index

Fig. 1: Comparison of state Medicaid fees for radiation oncology services for breast cancer and nonradiation oncology services per the Kaiser Family Foundation Index. (Agarwal et al, Red Journal, 2019) Credit: Elsevier

News | Radiation Therapy | April 22, 2019
April 22, 2019 — A new study finds wide state
Stereotactic Radiosurgery Effective for Pediatric Arteriovenous Malformation Patients
News | Radiation Therapy | April 19, 2019
Ching-Jen Chen, M.D., of the neurosurgery department at the University of Virginia (UVA) Health System, was the winner...
Video Plus Brochure Helps Patients Make Lung Cancer Scan Decision

Image courtesy of the American Thoracic Society

News | Lung Cancer | April 19, 2019
A short video describing the potential benefits and risks of low-dose computed tomography (CT) screening for lung...
In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images

In a demonstration on the exhibit floor of the SBI symposium, Koios software identified suspicious lesions in ultrasound images. Photo by Greg Freiherr

Feature | Artificial Intelligence | April 19, 2019 | By Greg Freiherr
Commercial efforts to develop...
Videos | Breast Imaging | April 18, 2019
In a keynote lecture at the Society of Breast Imaging (SBI)/American College of Radiology (ACR) 2019 Symposium, ...
Surgically Guided Brachytherapy Improves Outcomes for Intracranial Neoplasms
News | Brachytherapy Systems | April 18, 2019
Peter Nakaji, M.D., FAANS, general practice neurosurgeon at Barrow Neurological Institute, presented new research on...
Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer

Fatty tissue and breast density may be considered in the context of many factors that affect the occurrence and detection of breast cancer. Permission to publish provided by DenseBreast-info.org

Feature | Breast Imaging | April 18, 2019 | By Greg Freiherr
When planning a screening program to detect the early signs of breast cancer, age is a major consideration.
iCAD Appoints Stacey Stevens as President
News | Radiology Business | April 16, 2019
iCAD Inc. recently announced that Stacey Stevens has been named president. As president, Stevens will have expanded...
compressed breast during mammography.
360 Photos | 360 View Photos | April 16, 2019
A 360 view of a simulated breast compression for a...